Usefulness of Quantitative Assessment of JunB Gene Expression as a Marker for Monitoring Chronic Myeloid Leukemia Patients Undergoing Imatinib Therapy

• LIU Yi-Chang

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• HSIAO Hui-Hua

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• CHANG Jan-Gowth

  Department of Molecular Medicine, Chinese Medical University

• YANG Ming-Yu

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• LIU Ta-Chih

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• CHANG Chao-Song

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• TSENG Shih-Bin

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• TSAI Huei-Jen

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

• LIN Sheng-Fung

  Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital

Journal

• International journal of hematology

  International journal of hematology 84 (5), 425-431, 2006-12-15

Keywords

• JunB
• Imatinib mesylate
• BCR-ABL
• Real-time quantitative RT-PCR
• Chronic myeloid leukemia

Details

• CRID: 1573950400107547520
• NII Article ID: 10018670944
• NII Book ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2007202041
• Text Lang: en
• Data Source:
  • CiNii Articles